WALTHAM, Mass., Oct. 31, 2019 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its third quarter 2019 financial results on Thursday, November 7, after the clo

TEL AVIV, Israel, Oct. 31, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that it will deliver the following poster presentations at the S

LAVAL, Quebec, Oct. 31, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, announced that the U.S. Patent and Trade

DENVER, Oct. 31, 2019 /PRNewswire/ -- Nephrology Care Alliance (NCA), a new entity seeking to empower physicians to succeed in a changing health care environment, announced that it has confirmed interest from over 500 nephrologists to participate in the NCA platform, covering both chronic kidney disease (CKD) and end stage renal disease (ESRD) patients. NCA is a phy

RANCHO CORDOVA, Calif., Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order to better reflect its new strategic focus on becoming a key solution provider for ce

WESTBROOK, Maine, Oct. 31, 2019 /PRNewswire/ --Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by Companion Animal Group ("CAG") Diagnostics recurring revenue growth of 13% reported and 14% organic Delivers EPS of $1.24, representing 18% growth on a re

CHICAGO, Oct. 31, 2019 /PRNewswire/ -- Tiege Hanley, a company dedicated to creating Uncomplicated Skin Care for Men®, is doubling down on its donations to

WAYNE, Pa., Oct. 31, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company focused on marketing treatments for different types of pain and inflammation, today announced that its third quarter 2019 financial results will be released on Thursday, November 14, 2019. Following the announcem

CEDAR KNOLLS, N.J., Oct. 31, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, will announce financial results for the third quarter of 2019 on

TORONTO, Oct. 31, 2019 /PRNewswire/ - Baylis Medical announced today the first North American use of its EPstar™ Fixed Electrophysiology Catheters. The EPstar catheters make available the smallest diagnostic catheter in the North American electrophysiology market, allowing physicians to reach previously inaccessible areas of the heart for procedure mapping.